|
Market Closed -
Swiss Exchange
16:31:52 16/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 135.76 CHF | +1.27% |
|
+2.01% | +23.87% |
| 11-16 | Incyte says EU approves oral treatment for chronic skin disease | RE |
| 11-16 | Seawolf Therapeutics Emerges From Stealth With $100 Million, Enters Into Research and License Deal With Sanofi | MT |
| Market Cap | 305B 278B 256B 232B 437B 28,681B 452B 3,083B 1,222B 15,391B 1,146B 1,122B 48,753B | P/E 2026 * |
24.4x | P/E 2027 * | 19.1x |
|---|---|---|---|---|---|
| Enterprise Value | 339B 308B 285B 257B 485B 31,831B 502B 3,422B 1,356B 17,082B 1,272B 1,245B 54,108B | EV / Sales 2026 * |
5.87x | EV / Sales 2027 * | 5.41x |
| Free-Float |
91.66% | Yield 2026 * |
2.7% | Yield 2027 * | 2.84% |
| Markets | Quality | ||
|---|---|---|---|
Swiss Exchange
| NOVN | Delayed | |
| 0QLR | Real-time | ||
| NOT | Real-time | ||
| 1NOVN | End-of-day quote | ||
| 0QLR | Delayed | ||
| NOT | Delayed | ||
| NOT | End-of-day quote | ||
| NOT | Delayed | ||
| NOT | End-of-day quote | ||
| NOT | Real-time | ||
| NOT | Delayed | ||
| NVSEF | Delayed | ||
| Real-time | |||
| 0QLR | Real-time | ||
| NOVN | End-of-day quote |
Last Transcript: Novartis AG
| 1 day | +1.27% | ||
| 1 week | +2.01% | ||
| Current month | +1.48% | ||
| 1 month | +7.83% | ||
| 3 months | +10.88% | ||
| 6 months | +16.35% | ||
| Current year | +23.87% |
| 1 week | 132.48 | 137 | |
| 1 month | 123.64 | 137 | |
| Current year | 107.68 | 137 | |
| 1 year | 99.45 | 137 | |
| 3 years | 81.1 | 137 | |
| 5 years | 72.84 | 137 | |
| 10 years | 65.09 | 137 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 50 | 31/01/2018 | |
Mukul Mehta
DFI | Director of Finance/CFO | - | 15/03/2026 |
Karen Hale
CMP | Compliance Officer | 58 | 13/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Nancy Andrews
BRD | Director/Board Member | 67 | 31/12/2014 |
| Director/Board Member | 69 | 31/12/2015 | |
Ton Büchner
BRD | Director/Board Member | 61 | 31/12/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 18/05/26 | Sell | -5,200 | 0.0003% | |||
| 04/05/26 | Sell | 6,800 | 0.0003% | |||
| 17/02/26 | Sell | 30,743 | 0.0015% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.27% | +2.01% | +30.01% | +62.35% | 302B | ||
| -0.82% | +5.74% | +39.64% | +143.26% | 1,286B | ||
| -1.12% | +2.29% | +44.21% | +89.89% | 688B | ||
| -0.16% | +1.11% | +26.76% | +114.06% | 521B | ||
| +1.14% | +4.87% | +43.06% | +71.97% | 386B | ||
| -2.23% | -1.55% | +55.47% | +42.54% | 364B | ||
| +0.37% | +0.75% | +3.71% | +39.09% | 287B | ||
| -0.72% | +0.41% | +37.29% | +69.33% | 252B | ||
| -0.30% | +0.41% | +34.04% | +123.32% | 208B | ||
| +2.44% | +5.86% | -8.29% | -57.68% | 181B | ||
| Average | +0.52% | +2.20% | +30.59% | +69.81% | 448B | |
| Weighted average by Cap. | +0.07% | +3.26% | +35.14% | +91.95% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 57.75B 52.47B 48.48B 43.79B 82.64B 5,423B 85.55B 583B 231B 2,910B 217B 212B 9,218B | 61.7B 56.05B 51.79B 46.78B 88.28B 5,793B 91.39B 623B 247B 3,109B 232B 227B 9,848B |
| Net income | 12.75B 11.58B 10.7B 9.67B 18.24B 1,197B 18.88B 129B 50.99B 642B 47.83B 46.82B 2,035B | 15.68B 14.25B 13.16B 11.89B 22.44B 1,473B 23.23B 158B 62.73B 790B 58.85B 57.6B 2,503B |
| Net Debt | 33.55B 30.48B 28.17B 25.44B 48.01B 3,151B 49.7B 339B 134B 1,691B 126B 123B 5,356B | 28.34B 25.75B 23.79B 21.49B 40.56B 2,661B 41.98B 286B 113B 1,428B 106B 104B 4,524B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/11/26 | CHF 135.76 | +1.27% | 1,875,146 |
| 13/11/26 | CHF 134.06 | -0.12% | 3,376,655 |
| 12/11/26 | CHF 134.22 | +1.11% | 2,714,722 |
| 11/11/26 | CHF 132.74 | -1.29% | 3,528,282 |
| 10/11/26 | CHF 134.48 | +0.76% | 2,544,288 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- NOVN Stock
Select your edition
All financial news and data tailored to specific country editions

















